ישראל - עברית - Ministry of Health

trupharm marketing 1985 ltd. - epinephrine - תמיסה להזרקה - epinephrine 1 mg / 1 ml - epinephrine - epinephrine - epipen is indicated in the emergency self treatment of severe allergic reactions (anaphylaxis) to hymenoptera stings, biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens as well as idiopathic anaphylaxis or exercise induced anaphylaxis.it is designed as emergency supportive therapy only and is not a replacement or substitute for subsequent medical or hospital care

ישראל - עברית - Ministry of Health

trupharm marketing 1985 ltd. - epinephrine - תמיסה להזרקה - epinephrine 0.5 mg / 1 ml - epinephrine - epinephrine - epipen jr is indicated in the emergency self treatment of severe allergic reactions (anaphylaxis) to hymenoptera stings, biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens as well as idiopathic anaphylaxis or exercise induced anaphylaxis.it is designed as emergency supportive therapy only and is not a replacement or substitute for subsequent medical or hospital care.

ישראל - עברית - Ministry of Health

אנדומדיק בע"מ - כלל האוכלוסיה - חסם עורקים קרבי אישי להפעלה ביד אחת

ישראל - עברית - Ministry of Health

tzamal medical ltd - רופא - ניתוחי עמוד שידרה

ישראל - עברית - Ministry of Health

מדי פישר הנדסה ומדע (2002) בע"מ - מומחה - eye treatment and surgery with laser/uv technology

ישראל - עברית - Ministry of Health

tzamal medical ltd - רופא - לפי הוראות היצרן - לשימוש בניתוחי עמוד שידרה

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - methylprednisolone acetate - תרחיף להזרקה - methylprednisolone acetate 40 mg/ml - methylprednisolone - methylprednisolone - for the treatment of conditions responsive to steroid injection therapy.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - moroctocog alfa - אבקה מיובשת בהקפאה להזרקה - moroctocog alfa 500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - moroctocog alfa - אבקה וממס להכנת תמיסה להזרקה - moroctocog alfa 1000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - coagulation factor ix recombinant-rfix - אבקה מיובשת בהקפאה להזרקה - coagulation factor ix recombinant-rfix 250 iu/vial - coagulation factor ix - coagulation factor ix - benefix is indicated for the control and prevention of hemorrhagic episodes in patients with hemophilia b (congenital factor ix deficiency or christmas disease), including control and prevention of bleeding in surgical settings, in previously treated patients (ptp) and previously untreated patients (pup). benefix is not indicated for the treatment of other factor deficiencies (e.g. factors ii,vii, and x)' nor for the treatment of hemophilia a patients with inhibitors to factor viii, nor for the reversal of coumarin-induced anticoagulation, nor for the treatment of bleeding due to low levels of liver-dependent coagulation factors.